Web Analytics

3 Latest Announced Rounds

  • $37,000,000
    Series A

    1 Investors

    Biotechnology Research
    Jul 16th, 2024
  • $6,500,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jul 16th, 2024
  • $63,000,000
    Unknown

    1 Investors

    Automation Machinery Manufacturing
    Jul 16th, 2024
$2,164.70M Raised in 66 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Neuspera Medical Inc.

start up
United States - San Jose, CA
  • 16/07/2024
  • Series D
  • $23,000,000

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.


Related People

Steffen HovardFounder

Steffen Hovard United States - Minneapolis, Minnesota

A transformative Global Senior Executive in Medical Devices with full business scope experience leading all functional areas in stand-alone structures. I lead organizations to achieve what few thought possible.

I CREATE LONG-TERM FINANCIAL VALUE under complex circumstances through financial discipline, turnarounds, revenue growth, market expansion, pipeline management, and organizational integration and development. I excel at strategic planning and rallying organizations around goals and culture.

I develop companies, in cooperation with the management team, by developing and executing business strategy, setting priorities and processes, and developing the organization to sustainably strengthen financial performance. I have proven operational and executive leadership successes in both US and Europe.

MY LEADERSHIP APPROACH is based on directness, respect, and openness. As a solid decision maker and collaborator, I build consensus organization-wide and with key stakeholders.

AS PRESIDENT AND SVP OF COLOPLAST, INTERVENTIONAL UROLOGY I led a stand-alone division (US HQ) of a publicly traded company with full financial accountability (rev. ~$300M) and leadership across all functions and ~900 employees. The product portfolio included a wide range of Class I, II & III Medical Devices. Previously I held executive roles in France and Denmark for Coloplast.

CAREER HIGHLIGHTS
• Grew business value to $1B+ within 10 years
• Successfully turned around international business unit headquartered in France. Delivered ~8% annual organic revenue growth (2-3X market growth) and EBIT-% from double-digit negative to positive high single-digit.
• Successfully turned around US-based business unit to deliver ~9% annual organic revenue growth (2-3X market growth) and EBIT-% from single-digit negative to positive double-digit.
• Integrated two global business units into one US headquartered entity operating in 19 countries. Delivered 8-10% annual organic revenue growth (2-3X market growth) and accelerated EBIT-% to outperform industry benchmark.
• Key executive representative interacting with investment banks and presenting to potential buyers.

AN ACTIVE BOARD MEMBER & CHAIR, participation in numerous Board of Directors; for profit, non-profit and industry associations.

FUN FACTS
• Born in Denmark, I am fluent in English, Danish and basic working level in French and German.
• I am passionate about achieving long term sustainable business performance.
• I led the business to growth and continued development through and involvement in the largest mass tort in US history